igf-1-lr3-usa LR3 IGF-1 (Human), Recombinant Protein, CHO, Tag Free Recombinant Human LR3 IGF-I/IGF-1 GMP
Description
22,82 Sorafenib, as a multi-target kinase inhibitor, is clinically used for the treatment of unresectable hepatocellular carcinoma
Importantly, the expression of these genes is controlled by the transcription factor NRF2, and, in fact, the level of this protein was highly reduced in the most sensitive cell line, NCI H23, explaining the reduced expression of genes involved in GSH synthesis (Fig
doi: 10.3389/fimmu.2019.02729 32 BalasundaramPFarhanaA
The flow rate was 0.4 ml/min and the column temperature was 40C
